Factors that Impact Duration of Antibiotic Therapy from Phase 3 Studies of Eravacycline for Intra-Abdominal Infection
Presentation Number:
Author(s): Kenneth Lawrence, ; Erin Mathias, Veristat; Philip Barie, Weill Cornell Medicine, New York, NY; Larry Tsai, Tetraphase Pharmaceuticals
Eligible for the Sawyer Award